论文部分内容阅读
目的:探讨腹腔镜术后联合醋酸曲普瑞林治疗卵巢子宫内膜异位囊肿的临床疗效。方法:72例卵巢子宫内膜异位囊肿患者按自愿原则分为2组。对照组30例单纯行腹腔镜手术;观察组42例行腹腔镜术后联用醋酸曲普瑞林3.75 mg肌内注射,每28天1次,连用3个月。所有患者随访24个月,观察疗效、术后复发率和妊娠率。结果:观察组与对照组的有效率分别为78.6%(33/42)和43.3%(13/30),复发率分别为11.9%(5/42)和33.3%(10/30),自然妊娠率分别为46.7%(14/30)和18.2%(4/22),两组差异均有统计学意义(P<0.05)。结论:腹腔镜术后联合醋酸曲普瑞林治疗卵巢子宫内膜异位囊肿可以提高疗效,减少复发率,提高自然妊娠率。
Objective: To investigate the clinical efficacy of triptorelin acetate in the treatment of ovarian endometriosis after laparoscopic surgery. Methods: Seventy two patients with ovarian endometriosis were divided into two groups on a voluntary basis. Control group, 30 cases of simple laparoscopic surgery; 42 cases of observation group after laparoscopic surgery combined with triptorelin acetate 3.75 mg intramuscular injection, once every 28 days, once every 3 months. All patients were followed up for 24 months to observe the efficacy, recurrence rate and pregnancy rate. Results: The effective rates of the observation group and the control group were 78.6% (33/42) and 43.3% (13/30) respectively, the recurrence rates were 11.9% (5/42) and 33.3% (10/30) respectively. The natural pregnancy Rates were 46.7% (14/30) and 18.2% (4/22), respectively, with significant differences between the two groups (P <0.05). Conclusion: Laparoscopic combined with triptorelin acetate treatment of ovarian endometriosis cysts can improve the efficacy, reduce the recurrence rate and improve the rate of natural pregnancy.